Why is Saroja Pharma In falling/rising?

As of 20-Oct, Saroja Pharma Industries India Ltd is experiencing a decline in its stock price, currently at 43.60, which reflects a decrease of 2.0 or 4.39%. The stock has underperformed its sector by 5.07% today, and while it is higher than the 100-day moving average, it is lower than the 5-day, 20-day, 50-day, and 200-day moving averages. Over the past week, the stock has dropped by 7.43%, and year-to-date, it has decreased by 27.33%. Notably, there has been a significant rise in investor participation, with delivery volume increasing by 233.33% against the 5-day average, indicating some interest despite the overall negative performance. Unfortunately, there is no available information regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, Saroja Pharma's short-term performance has been notably weaker compared to the benchmark Sensex, which has gained 2.44% over the past week. The stark contrast is evident as the stock has not only underperformed in the short term but also shows a significant decline over the past month and year, with losses of 3.43% and 28.23%, respectively. The Sensex, in contrast, has shown positive returns of 2.04% over the last month and 3.98% over the past year, highlighting the challenging environment for Saroja Pharma in comparison to the overall market performance.